You are here

  • Home
  • Archive
  • Volume 21, Issue Suppl 1
  • CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

Article metrics

Article menu
Download PDFPDF
Clinical Pharmacy
CP-066 Interleukin-28B polymophism as a predictor of response to telaprevir-based regimens in patients with hepatitis C virus genotype 1 infection

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 20141501
Mar 2014300
Apr 2014100
May 2014100
Jun 2014200
Jul 2014500
Aug 2014200
Sep 2014100
Oct 2014200
Nov 2014700
Dec 2014400
Jan 2015900
Feb 2015300
Mar 2015202
Apr 2015600
May 2015200
Jun 2015100
Sep 2015100
Dec 2015300
Jan 2016200
Jun 2016100
Jul 2016401
Aug 2016901
Sep 2016600
Oct 2016200
Nov 2016400
Dec 2016500
Jan 2017600
Feb 2017200
Mar 2017400
Apr 2017300
May 2017200
Jun 2017500
Jul 2017800
Aug 20171400
Sep 20171000
Oct 20171100
Nov 20171800
Dec 20172000
Jan 20183800
Feb 20184800
Mar 20185400
Apr 20185600
May 20188400
Jun 20183200
Jul 20182000
Aug 20181200
Sep 20182000
Oct 20182600
Nov 20184000
Dec 20184800
Jan 20194000
Feb 20193800
Mar 20191000
Jul 2019600
Sep 2019600
Oct 20191000
Nov 2019200
Dec 2019200
Jan 20201400
Feb 2020400
Jun 2020700
Jul 20201200
Aug 2020400
Sep 20201400
Oct 20205200
Nov 20204000
Dec 2020300
Jan 20211102
Feb 2021400
Apr 2021200
May 2021200
Oct 2021600
Nov 20211801
Dec 2021603
Jan 2022800
Feb 2022300
Mar 2022800
Apr 2022400
May 2022600
Jun 20221000
Jul 20221200
Aug 20221000
Sep 2022400
Oct 20221400
Nov 2022800
Dec 20221200
Jan 2023200
Feb 2023400
Mar 2023400
Apr 2023200
May 20231000
Jun 2023600
Jul 2023600
Aug 2023400
Sep 2023600
Nov 2023600
Dec 2023200
Jan 2024800
Feb 2024200
Mar 2024600
Total1164011